NovoCure (NVCR) Tax Rate Growth (1y) (2015 - 2026)
NovoCure (NVCR) Tax Rate Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,100.00 |
| Mar 31, 2026 | 1,057.00 |
| Dec 31, 2025 | 5,959.00 |
| Sep 30, 2025 | 1,748.00 |
| Jun 30, 2025 | 3,209.00 |
| Mar 31, 2025 | 921.00 |
| Dec 31, 2024 | 276.00 |
| Sep 30, 2024 | -3,901.00 |
| Jun 30, 2024 | -4,032.00 |
| Mar 31, 2024 | -1,862.00 |
| Dec 31, 2023 | -760.00 |
| Sep 30, 2023 | 1,087.00 |
| Jun 30, 2023 | -373.00 |
| Mar 31, 2023 | 8,089.00 |
| Dec 31, 2022 | -1,111.00 |
| Sep 30, 2022 | 1,111.00 |
| Jun 30, 2022 | 783.00 |
| Mar 31, 2022 | -3,378.00 |
| Dec 31, 2021 | -4,774.00 |
| Sep 30, 2021 | -4,050.00 |